The University of Texas, 1 University Station A2700, Painter Hall, Room 5.32, Austin, TX 78712, USA
J Clin Oncol. 2010 Sep 10;28(26):4058-65. doi: 10.1200/JCO.2010.27.9935. Epub 2010 Aug 9.
Obesity is associated with an increased risk and worsened prognosis for many types of cancer, but the mechanisms underlying the obesity-cancer progression link are poorly understood. Several energy balance-related host factors are known to influence tumor progression and/or treatment responsiveness after cancer develops, and these have been implicated as key contributors to the complex effects of obesity on cancer outcome. These host factors include leptin, adiponectin, steroid hormones, reactive oxygen species associated with inflammation, insulin, insulin-like growth factor-1, and sirtuins. Each of these host factors is considered in this article in the context of energy balance and cancer progression. In addition, future research directions in this field are discussed, including the importance of study designs addressing energy balance across the life course, the development and application of highly relevant animal models, potential roles of cancer stem cells in the response to energy balance modulation, and emerging pharmacologic approaches that target energy balance-related pathways.
肥胖与多种癌症的风险增加和预后恶化有关,但肥胖与癌症进展之间的联系的机制尚不清楚。已知有几个与能量平衡相关的宿主因素会影响癌症发生后肿瘤的进展和/或治疗反应性,这些因素被认为是肥胖对癌症结果的复杂影响的关键因素。这些宿主因素包括瘦素、脂联素、类固醇激素、与炎症相关的活性氧、胰岛素、胰岛素样生长因子-1 和沉默调节蛋白。本文将从能量平衡和癌症进展的角度考虑这些宿主因素中的每一个。此外,还讨论了该领域未来的研究方向,包括在整个生命周期中解决能量平衡的研究设计的重要性、高度相关的动物模型的开发和应用、癌症干细胞在对能量平衡调节的反应中的潜在作用,以及针对能量平衡相关途径的新兴药物治疗方法。